Finding the best treatment approach for children with language impairment
Determining Optimal Treatment Intensity for Children with Language Impairment (LI)
This study is looking at how different amounts of help can improve vocabulary learning in young kids aged 5 to 6 who have trouble with language, to find out the best way to support them in learning new words.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10548217 on NIH RePORTER |
What this research studies
This research investigates how different levels of treatment intensity affect vocabulary learning in young children aged 5 to 6 years with language impairment. By varying the number of treatment sessions and the frequency of those sessions, the study aims to identify the most effective way to help these children improve their language skills. The research will utilize a structured intervention that focuses on word learning, assessing how often and how much children should be exposed to new vocabulary to achieve the best outcomes. This approach is grounded in established learning theories and seeks to optimize treatment strategies for better educational support.
Who could benefit from this research
Good fit: Ideal candidates for this research are young children aged 5 to 6 years who have been diagnosed with language impairment.
Not a fit: Children who do not have language impairment or are outside the age range of 5 to 6 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective interventions that significantly enhance vocabulary development in children with language impairment.
How similar studies have performed: Previous research has shown promising results in optimizing treatment intensity for language interventions, suggesting that this approach could yield beneficial outcomes.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Schmitt, Mary Beth — University of Texas at Austin
- Study coordinator: Schmitt, Mary Beth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.